Rapid dissemination of alpha-synuclein seeds through neural circuits in an in-vivo prion-like seeding experiment

Acta Neuropathol Commun. 2018 Sep 19;6(1):96. doi: 10.1186/s40478-018-0587-0.

Abstract

Accumulating evidence suggests that the lesions of Parkinson's disease (PD) expand due to transneuronal spreading of fibrils composed of misfolded alpha-synuclein (a-syn), over the course of 5-10 years. However, the precise mechanisms and the processes underlying the spread of these fibril seeds have not been clarified in vivo. Here, we investigated the speed of a-syn transmission, which has not been a focus of previous a-syn transmission experiments, and whether a-syn pathologies spread in a neural circuit-dependent manner in the mouse brain. We injected a-syn preformed fibrils (PFFs), which are seeds for the propagation of a-syn deposits, either before or after callosotomy, to disconnect bilateral hemispheric connections. In mice that underwent callosotomy before the injection, the propagation of a-syn pathology to the contralateral hemisphere was clearly reduced. In contrast, mice that underwent callosotomy 24 h after a-syn PFFs injection showed a-syn pathology similar to that seen in mice without callosotomy. These results suggest that a-syn seeds are rapidly disseminated through neuronal circuits immediately after seed injection, in a prion-like seeding experiment in vivo, although it is believed that clinical a-syn pathologies take years to spread throughout the brain. In addition, we found that botulinum toxin B blocked the transsynaptic transmission of a-syn seeds by specifically inactivating the synaptic vesicle fusion machinery. This study offers a novel concept regarding a-syn propagation, based on the Braak hypothesis, and also cautions that experimental transmission systems may be examining a unique type of transmission, which differs from the clinical disease state.

Keywords: A-syn; Callosotomy; Propagation; Rapid dissemination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid / toxicity
  • Animals
  • Botulinum Toxins, Type A / metabolism
  • Brain / pathology*
  • Dopamine and cAMP-Regulated Phosphoprotein 32 / metabolism
  • Functional Laterality
  • Humans
  • Mice, Inbred C57BL
  • NAV1.2 Voltage-Gated Sodium Channel / metabolism
  • Nerve Net / pathology*
  • Neurons / metabolism*
  • Neurons / pathology
  • Parkinson Disease / pathology*
  • Prion Diseases / pathology*
  • Protein Transport
  • Synaptic Vesicles / drug effects
  • Synaptic Vesicles / physiology
  • Time Factors
  • Tyrosine 3-Monooxygenase / metabolism
  • alpha-Synuclein / metabolism*

Substances

  • Amyloid
  • Dopamine and cAMP-Regulated Phosphoprotein 32
  • NAV1.2 Voltage-Gated Sodium Channel
  • alpha-Synuclein
  • rimabotulinumtoxinB
  • Tyrosine 3-Monooxygenase
  • Botulinum Toxins, Type A